Source:http://linkedlifedata.com/resource/pubmed/id/21595265
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-5-19
|
pubmed:abstractText |
Incretins including GLP-1 and GIP have pleiotropic effects on islet biology especially on beta-cell function. Not only enhancing glucose-stimulated insulin secretion, but incretins exert beta-cell mass maintaining effects by upregulation of proliferation and prevention of cell death (apoptosis). Recent research data revealed detailed molecular mechanisms underlying these effects of incretin on beta-cell biology. These beneficial effects of incretins on the regulation of beta-cell mass could contribute to future therapeutic approaches to diabetes focusing on preservation and upregulation of beta-cell mass as well as function.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0047-1852
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
821-5
|
pubmed:dateRevised |
2011-7-27
|
pubmed:meshHeading | |
pubmed:year |
2011
|
pubmed:articleTitle |
[Effects of incretins on the regulation of beta-cell mass, proliferation and survival].
|
pubmed:affiliation |
Department of Metabolic Medicine, Osaka University Graduate School of Medicine.
|
pubmed:publicationType |
Journal Article,
English Abstract
|